Magnetic hyperthermia which exploits the heat generated by magnetic nanoparticles (MNPs) when exposed to an alternative magnetic field (AMF) is now in clinical trials for the treatment of cancers. However, this thermal therapy requires a high amount of MNPs in the tumor to be efficient. On the contrary the hot spot local effect refers to the use of specific temperature profile at the vicinity of nanoparticles for heating with minor to no long-range effect. This magneto-thermal effect can be exploited as a relevant external stimulus to temporally and spatially trigger drug release. In this review, we focus on recent advances in magnetic hyperthermia. Indirect experimental proofs of the local temperature increase are first discussed leading to a good estimation of the temperature at the surface (from 0.5 to 6 nm) of superparamagnetic NPs. Then we highlight recent studies illustrating the hot-spot effect for drugrelease. Finally, we present another recent strategy to enhance the efficacity of thermal treatment by combining photothermal therapy with magnetic hyperthermia mediated by magneto-plasmonic nanoplatforms.
a b s t r a c t a r t i c l e i n f o (MNPs). MHT has been extensively investigated both theoretically and experimentally to reach a therapeutic efficacy. Activating the MNPs located deep inside the tissues or organs by MHT can be accomplished at frequencies (f) and field (H) conditions that do not harm the human body (H x f ≤ 5 × 10 8 A/m.s) [1] When exposed to alternative magnetic field (AMF) of appropriate amplitude and frequency, MNPs release heat, which reduces the viability of cancer cells through apoptotic or necrotic pathways. Such nanothermo-therapy is already in clinical trials (e.g. phase II for glioblastoma multiforme, MagForce, Berlin, http://www.magforce.de/en/home.html) and received a European market authorization. [2] For superparamagnetic MNPs, magnetic loss responsible for converting magnetic energy into heat under AMF is attributed to Néel-Brown relaxations. [3] Magnetic heating is attractive as a physical modality for cancer treatment due to specific features such as non-invasiveness, no depth penetration limit, remote controllability, nanoscale spatial resolution, and molecular-level specificity. However, magnetic hyperthermia still suffers from critical drawbacks, including the need for a high dose of MNPs (usually 1-2 M, which is a few orders of magnitude larger than contrast agent used for MRI) or therapeutic resistance arising from self-protective mechanisms of cancer cells against the applied thermal stress.
In recent years, in order to overcome such limitations, new approaches based on multimodal synergistic therapy, employing the integration of two or more form of treatment, were developed. [4] Multimodal synergistic therapy is defined as the cooperation among different treatments integrated into a single nanoplatform whose yields enhanced therapeutic effects compared to the individual treatments.
The combination of multiple modalities in a single system is possible thanks to a smart design of multifunctional nanomaterials. The first approach for multimodal therapy is to combine a physical treatment (MHT, photothermal therapy (PTT), high intensity focused ultrasound (HIFU) and others) and a chemotherapy in the same platforms. Numerous magnetic systems were designed to trigger drug release by MHT but only few of them managed to release the drug by hot spot local effect, meaning in global athermal conditions.
In this review we will first focus on the heat generated by MNPs at the nanometer scale to magnetically induce drug release from polymeric platform. This local heat delivery and subsequent therapeutic drug release is complementary to single-handed MHT. Besides, AMF may provide remote regulation of the amount of drug release, enhancement of the therapeutic effectiveness and decrease of systemic toxicity, notably through spatial and temporal control of drug release. Second, we will present another recent strategy to enhance the efficacy of thermal treatment, by combining PTT with MHT, mediated by magnetoplasmonic nanoplatforms.
Magnetic hyperthermia for remotely triggered drug delivery in athermal conditions

The hot spot effect
The last 20 years have witnessed an important increase in the number of reports dedicated to magnetic hyperthermia. Many have focused on the "hot spot effect" which refers to the use of specific temperature profile at the vicinity of nanoparticles (nano-assemblies) for heating with minor to no long-range (macroscopic) effect. Such an approach has numerous advantages. First, the effect becomes less dependent on the number of nanoparticles usually required to increase significantly the macroscopic temperature in the targeted area. Hence, no major stress is applied to the biological environment, allowing a better recovery of neighboring healthy cells or organs. The toxicity is thus strongly limited and side-effects of magnetic nanoparticles are dramatically reduced. Secondly, the thermal profile around the nanoparticles can induce drug release without thermally damaging the areas of interest. Once again, side-effects should be limited. Additionally, nanoparticle aggregation, that often occurs in cellular environment and limits the macroscopic heating efficiency of magnetic nanoparticles, should not impact the local temperature effect as it impacts the macroscopic heating efficiency [5] [6] [7] .
Last, very local effects can be triggered, without damaging other organelles within the cells. For instance, Huang et al. demonstrated that nanoparticles targeted to the outer membrane of cells can activate ions channels with very local temperature increase without thermally affecting the Golgi apparatus [8] .
Hot spot effect requires evidence of the heating efficiency at the local stage. These proofs could be indirect (evaluation of a thermal effect to a physical property) or a direct evaluation of the thermal gradient in the area of interest. Most recent publications elucidate the indirect role of local heat generation.
Most "hot spot" effects are triggered by thermosensitive reactions. N'Guyen et al. described a retro-Diels-Alder reaction conducted through hyperthermia excitation on maghemite nanoparticles functionalized with multifunctional ligands that use maleimide to link a furanterminated moiety as thermosensitive linkers [9] . They evidenced a fluorophore release proportional to the excitation duration and the nanoparticles concentration, with no macroscopic temperature increase. The same retro-Diels-Alder reactions were used and monitored by magnetic hyperthermia on (Zn 0.4 Mn 0.6 )Fe 2 O 4 magnetic nanoparticles in mesoporous silica employed as cargo by Rühle et al. [10] The pores of the cargos were closed with molecules that act as nanovalves and could liberate the payload by the thermosensitive reaction. This reaction allowed to control the molecular release above 65°C, as shown in Fig. 1 . Jaque et al. explored new nanothermometric methods combining light emission properties of luminescent nanoparticles in the NearInfrared (NIR) range with nanoheaters under magnetic field. [11] The release of fluorescein with AMF stimulation demonstrated that the surface temperature of the cargos reaches at least 65°C, about 20 nm apart from the magnetic particle surface.
Thermosensitive block copolymers were also reported for surface functionalization of magnetic nanoparticles by Polo-Corrales and Rinaldi [12] . The authors demonstrated that a rapid temperature increase occurs in the immediate vicinity of the nanoparticles while the macroscopic temperature increases more slowly in the bulk. They concluded that their polymer (PNIPAM) crossed the lower critical solution temperature (LCST) even though the medium has not reached this critical value. Very recently grafting molecularly imprinted polymers (MIP) on iron oxide nanoparticles was reported by Griffete et al. for drug delivery applications [13] . The release of doxorubicin was significantly increased when particles were submitted to the AMF stimulation [13] . The release rate was comparable to the one obtained at temperature higher than 50°C, which gave an evaluation of the mean temperature in the polymer corona around the magnetic core (10-30 nm). More recently, the direct radical polymerization of the MIP layer through hyperthermia excitation at moderate temperature was also evidenced by the same group [14] . This polymerization usually occurs at 60°C, but it could be achieved at temperature below 31°C under magnetic activation, confirming the temperature increase proposed in the previous work. Similar results were obtained by Guisasola et al. who elaborated nanocarriers made of iron oxide nanoparticles embedded in a silica shell loaded with fluorescein and modified with an outer shell of thermosensitive polymer (NIPAM/NHMA) [15] . In this nanoarchitecture, despite the fact that the iron oxide core is 20 nm away from the surface of the carrier, LCST transition was observed under magnetic stimulation. Moreover, the release of fluorescein was demonstrated to be more efficient in isothermal condition with magnetic stimulation than with macroscopic heating.
Taken together, these results show that local thermal effect could be of outmost importance for the next generation of magnetic carriers for therapeutic applications. These systems will need a more careful characterization and nano-investigations toward specific and controlled effects.
While the "hot-spot" effect has started to be explored indirectly from macroscopic observations of nanoscale-derived effects, the direct evaluation at the nanoscale of the local temperature profile around the nanoparticles is less investigated. To reach such information Dong and Zink used the dependence of fluorescence on up-conversion emission spectrum of NaYF 4 :Yb
3+
,Er 3+ nanoparticles embedded into mesoporous silica matrix with magnetic particles [16] . The temperature was measured in the silica matrix, but without precision on the temperature around the magnetic nanoparticle. However, compared to bulk where a temperature increase of only 20°C was observed, the authors distinguished a more rapid temperature increase, reaching up to 45°C above the starting temperature around the nanoparticles. Even though the gradient of temperature was not elucidated exactly at the surface of magnetic nanoparticles, this proof of concept is of prime importance to establish temperature profile in the vicinity of hot spots. Alternatively, DNA coupled with fluorophores can be also used as a local thermometer [17] . Gareau et al. demonstrated that nonexpensive DNA strands could be used with good sensitivity (0.05°C) in a large range of temperature (30°C to 85°C). They showed that the combination of thermoswitches allows large gain of fluorescence for very low temperature variation. This strategy could benefit to the temperature measurement around hot spots. Equivalently, Dias et al. used the hybridization of DNA to measure precisely the temperature at the surface of iron oxide nanoparticles [18] . They were able to report variations of temperature (in comparison to the macroscopic one) of 8.3°C at 5 nm from the nanoparticle surface to 6.1°C at 5.6 nm.
Another example on the use of DNA is given by Yu et al. [19] . The authors evaluated the thermodynamic equilibrium between the hybridization and denaturation of double-stranded DNA. This strategy is less straightforward because it needs the separation of the unlinked DNA strands from the bulk dispersion ("rapid" separation is achieved). On the more, their results depend strongly on the excitation time, and the temperature increase between the surface of the nanoparticles and the bulk is reported to be approximatively 50-60°C, with no direct determination of the exact distance of the DNA from the surface. It is just stated that the difference in temperature is given "at the surface" compared to the bulk.
Polymers can also be used as spacers between the surface of iron oxide nanoparticles and a thermo-sensitive linker. Riedinger et al. prepared 15 nm diameter iron oxide nanoparticles coated with polyethylene glycol (PEG) oligomer terminated by a fluoresceine-amine dye attached to a thermolabile azo linker [20] . The length of the PEG was modified from 500 g/mol to 1500 g/mol, and 8000 g/mol. These molecular weights allowed to reach different distances from the surface of the nanoparticle: 0.47 nm, 0.83 nm, and 1.9 nm. The temperature increases (above the bulk temperature) measured at those distances are 42°C, 26°C, and 11°C, respectively. In this example, the distances are closer to the surface of the particles, compared to the work of Dias et al. who recorded the temperature at 5-6 nm from the surface.
These nanoparticles were not synthesized by the same method, have different sizes, and different magnetic excitation parameters (magnetic field amplitudes and frequencies). However, all results collapse to a unique image showing a strong thermal gradient from the surface of the nanoparticles to the surrounding medium (Fig. 2) . A unique study combining short and large distance measurements on the same system is still missing. Interestingly, in another study made in our group, with another system involving AMF-mediated thermo-polymerization at the surface of MNPs, the extrapolation of the temperature profile, yet less resolved, is in good agreement with the reported data of Fig. 2 .
Finally, we must emphasize that, while MHT has been extensively studied for thermal therapy and drug delivery, exploring the "hotspot" effect is still in its infancy. Hybrid materials combining a magnetic and a polymeric component (thermoresponsive, molecularly imprinted) have shown to be very promising for local heating applications in drug delivery and hyperthermia therapy and will be reviewed thoroughly in the following sections of this paper. [20] , Dias et al. [18] , Griffete et al. [14] , and N'Guyen 9 Reproduced with permission from ref. [14, 18, 20, 9] respectively.
Magnetic thermoresponsive polymeric nanosystems
In the last few years, triggered drug delivery, especially using AMF [21] , attracted a lot of attention. Magnetic mesoporous silica nanoparticles were the main focus of numerous studies, as they are a promising platform for cancer therapy [22] due to their potential in chemotherapeutic drug delivery and hyperthermia therapy under an AMF. For example, Ruiz-Hernandez et al. synthesized γ-Fe 2 O 3 /mesoporous silica microspheres, and found that these magnetic microspheres showed a sustained drug release behavior and ability to generate heat under a low-frequency AMF [23] . Alternatively Lu et al. reported the preparation of 100 nm magnetic hollow mesoporous silica nanocapsules, and these nanocapsules showed magnetic field induced heating and remotely triggered drug release capabilities, which is promising for the combination of hyperthermia and chemotherapy [24] . The applications of silicabased nanomaterials in drug delivery and nanotherapy applications have been reviewed elsewhere [25, 26] , herein we will only focus on organic polymer based materials as micro-and nano-gels and molecularly imprinted polymer which, when combined with MNPs, offer intriguing opportunities regarding the development of a novel class of nanomaterials for drug delivery.
Due to their versatile macromolecular structures, polymers can serve as flexible nanoplatforms. A large portfolio of polymers with interesting physico-chemical properties have been developed with a special focus on those that exhibit structural or conformational changes in response to different stimuli. The release of drug can be achieved either by local biological stimuli (pH, redox, enzymes) or by externally applied radiation (light/electromagnetic fields, focused ultrasound). However biological environments offer no possibility of remote activation or dose control over drug release, contrary to external triggers which present advantages to achieve drug release with spatiotemporal and/or on demand control.
A highly comprehensive review dealing with the remote release by AMF of different drug delivery nanoplatforms (liposomes, polymersomes, capsules) has been published elsewhere [27] . Local drug delivery controlled by an external stimulus using nanoparticulate systems has emerged as a very promising strategy for nanomedicine. However, this requires a specific and well-controlled design.
Synthesis of thermosensitive magnetic micro and nanogels
Thermosensitive magnetic micro and nanogels are crosslinked polymer networks, capable of absorbing large quantities of drugs and water in the swelling state, and containing magnetic nanoparticles, that can be heated when exposed to an alternative magnetic field. In any case, the drug release is activated by an AMF-generated local heating (at nmscale) which may be mutualized with magnetic hyperthermia if macroscopic temperature elevation reaches a threshold, typically 43°C. In other words, magnetically induced drug release can occur in the local "hot spot" condition without macroscopic temperature elevation.
Thermosensitive magnetic micro-or nanogels are typically made of thermosensitive, hydrophilic and functional polymers, which can be physically or chemically crosslinked to form a gel network and presenting a volume phase transition temperature (VPTT) or a LCST. The local temperature can generate the swelling-deswelling transition of the nanogels, thus remotely trigger drug release.
Among these functional polymers, Poly(N-isopropylacrylamide) (PNIPAm) is considered a gold standard material for preparing thermoresponsive nanodevices. Despite its low LCST (32°C) the temperature can be easily tuned above 37°C by simply copolymerizing NIPAm with more hydrophilic monomers.
Magnetic micro or nanogels can be classified according to the nature of the interaction between the MNPs and the polymer chains (covalent or hydrogen bonds), the morphology of the gel (core or core@shell) and the distribution of MNPs within the polymer matrix (inside or at the surface of the matrix). For their synthesis, MNPs can be introduced before or after the polymerization step; or can be synthesized in situ in the nanogels' matrix.
Kondo et al. synthesized magnetic nanogels of PNIPAm by adding Fe 3 O 4 NPs before the polymerization process. To allow the dispersion of the Fe 3 O 4 NPs, the authors synthesized a polystyrene shell (PS) around the NPs. This shell also allows to interact with growing PNIPAm chains and to aid polymerization around the MNPs [28] . Nevertheless, it is neither possible to control the diameter of the nanogels (100 to 400 nm), nor the quantity of incorporated MNPs (5-20% by mass) using this method [28, 29] . Recently, the effect of NPs stabilization on the synthesis of Fe 3 O 4 /PNIPAm hybrid nanogels has been studied by Jaiswal et al. [30] . In this study, different ligands (citric acid, ethylene diamine, chitosan) were used. The authors showed that the mass ratio in NPs (%) inside the nanogels is increased, up to 40%, by stabilizing MNPs in the solution during the polymerization reaction. Using this method, it is possible to develop hybrid nanogels in a single step. However, it is very difficult to control the physico-chemical properties of nanogels (size, polydispersity, distribution of NPs within the polymer matrix), as well as the amount of MNPs incorporated into the matrix. In addition, the polymerization of the monomers in the presence of MNPs tends to form a core-shell structure, with a core containing mainly MNPs and a shell composed essentially of polymer.
Otherwise, Kumacheva et al. synthesized pH-and thermosensitive hybrid PNIPAm nanogels functionalized with acrylic acid (AA), by forming in situ the iron oxide NPs in the polymer matrix [31] . In the same way, Kawaguchi et al. used functionalized PNIPAm nanogels with glycidyl methacrylate (GMA) groups, to prepare the MNPs inside the polymer matrix [32] [33] [34] . The incorporation of GMA groups is very interesting because these groups can be modified after polymerization to introduce various active functions, such as amine, carboxylate and sulfonate, by post-modification with thiol compounds.
Furthermore, the synthesis of magnetic nanogels can be carried out by a post-synthesis assembly of thermosensitive nanogels and inorganic MNPs. The constituents (nanogels and MNPs) are synthesized separately before being assembled by electrostatic interactions, by formation of complexes or by covalent bonds between nanogels and MNPs. In this way, Pichot et al. prepared negatively charged MNPs coated with sodium citrate and positively charged nanogels functionalized with amine groups [35, 36] . The assembly of these objects takes place at pH 7.0, however if the pH is modified, the desorption of NPs is observed. One advantage of post-assembly process is that it allows the tuning of the magnetic and thermoresponsive properties of individual components (nanoparticles and microgels) separately before assembling them.
Huge efforts were dedicated to the synthesis of these magneticthermoresponsive polymers platforms. However their heat responsiveness was often tested by using a water bath rather than AMF.
Drug delivery under AMF
PNIPAm magnetic microgels were prepared by R. Regmi et al. by adding Fe 3 O 4 nanoparticles inside the polymeric matrix after the radical polymerization of microgels [37] . These nanogels have a LCST around 38°C and show substantial heating, reaching 50°C in only 4 min, and releasing 1% of the drug (mitoxantrone) per minute, when exposed to an AMF (380 kHz; 10.3 kA.m
−1
). M. Jaiswal and co-workers also prepared PNIPAm magnetic nanogels, but Fe 3 O 4 nanoparticles were entrapped in the polymer matrix during the polymerization process [38] . These nanogels (hydrodynamic diameter 200 nm) have a LCST of 40°C and are able to induce a two-fold increase of the drug release (doxorubicin) under AMF (5 kW, 230 kHz, 1 h) without macroscopic heating. These nanogels induced a cell death of 80% after 1 h of AMF (HeLa cells). J. Wong and co-workers prepared microgels by a layer-by-layer assembly of polyelectrolytes (adding successively positively charged poly (diallyldimethylammonium chloride) (PDADMAC) and negatively charged poly(acrylic acid) in order to facilitate the deposition of MNPs at the surface of PNIPAm nanogels [39] . The as prepared nanogels (d h = 190 nm, LCST around 32°C) are able to heat above 50°C in b30 s when applying an AMF (360 kHz, 20 kA.m
). Thus, the magnetic shell generates enough heat to provoke the deswelling of the PNIPAm core.
Although the NIPAm monomer is highly cytotoxic, it has been shown in the literature that the cytotoxicity of the PNIPAm polymer is less or even zero. However, after several purification steps, the PNIPAm crosslinked matrices may still contain monomers, making the system toxic [40, 41] . In addition, PNIPAm can also interact with human body proteins due to the presence of several amide functions in its chemical structure [42] . Thus, it is very difficult to use this polymer for biomedical applications. Otherwise, some natural polymers, such as alginate, have also been used for designing biocompatible magnetic microgels. C. Ménager et al. [43] prepared magnetic alginate microbeads by microemulsion polymerization and loaded with doxorubicin (DOX) and γ-Fe 2 O 3 NPs. DOX released was enhanced from these nanogels, from 25.9 μg.mL −1 (water bath at 37°C) to 60 μg.mL −1 , by applying an AMF (700 kHz, 26 mT, 2 h). Recently, magnetic nanogels based on biocompatible, water-soluble and non-toxic monomers derived from oligo (ethylene glycol methyl ether methacrylate) monomers (OEGMAs) have been synthesized [44] [45] [46] . Cazares-Cortes et al. synthesized pH and thermoresponsive OEGMAs-nanogels by conventional precipitation radical copolymerization in water and post-assembled by complexation with γ-Fe 2 O 3 NPs [47] . This method provides monodisperse nanogels with a high content of homogeneously distributed magnetic nanoparticles. The mass ratio of loaded MNPs inside nanogels can be tuned from 9.0 to 37.5 wt% (Fig. 3a) . Biocompatible nanogels (hydrodynamic diameter from 328 to 460 nm, LCST = 47°C at pH 7.5), containing 37.5 wt% MNPs, have a high drug loading efficiency (63%). The release of doxorubicin (DOX) from the nanogels can reach 47% at pH 7.5 under AMF (24% without AMF) in athermal conditions. Here, magnetic nanoparticles act as individual nanoheaters or "hot-spots". They generate a localized heating, without raising the global temperature of the media. The heat is enough to provoke the phase transition of the polymers chains. Interestingly, it was demonstrated that these nanogels are excellent nanocarriers for enhancing the internalization of DOX inside PC-3 cancer cells and that it is possible to trigger intracellularly and remotely DOX release under AMF (335 kHz, 12 A.m ), thus enhancing DOX efficiency in terms of cytotoxicity. Cancer cell viability was reduced from 51 to 32% in the presence of DOX-nanogels and (DOX-nanogels+AMF), respectively (Fig. 3b) .
Multi-responsive nanogels, combining two or more stimuli, are useful for treating diseases characterized by the variation of an internal parameter (temperature, pH, redox composition). For example, anticancer therapies must be improved by using nanocarriers sensitive to both acidic media and AMF. Indeed, the pH variation between the physiological environment of normal cells (pH 7.5) and cancer cells (pH 4.5-6.5) would enhance drug release inside cancer cells [48] [49] [50] . In addition, using an AMF as external stimulus may provide regulation of the amount of drug released, enhancement of the therapeutic effectiveness and decrease of systemic toxicity, notably through spatial and temporal control of drug release.
In vivo drug release under AMF
Despite the large portfolio of thermoresponsive nanosystems tested in vitro, only few studies have demonstrated the efficacy of AMF for in vivo drug release. [51, 52] Injectable hydrogel that undergoes a gelation process at 37°C, keeping the MNPs at the tumor site and causing a heat mediated release of encapsulated necrotic factors was developed. MNP were also clustered inside a poly(pyrrole carboxylic acid) exhibiting a glass transition at 44°C and loaded with DOX. The material injected intratumorally was able to cause complete tumor suppression due to the dual MHT heat (44°C) and chemotherapeutic effect [53] .
Efficient drug releasing magnetic polymeric NPs for anti-epileptic applications, based on thermosensitive PEO-PPO-PEO(F127) triblock copolymer nanogels bound with PVA and loaded both with magnetic NPs and ethosuximide (ETX), a calcium channel blocker for antiepilepsy applications were recently developed [54] . After intravenous injection and magnetic targeting of the NPs toward the rat brain, the reduction of epileptic episodes measured by electrophysiological recording was demonstrated through the decrease of the spike-wave discharges (SWD) over 2 h, upon the AMF-induced (2.5 kAm −1 , 44.2 kHz, 15 s) burst release of ETX (Groupe I) whereas free ETX administered (1 h, Groupe III) or ETX-loaded PVA (Groupe II) nanogels were shown not efficient (Fig. 4a) . Injectable, biodegradable and thermosensitive TRAIL/SPION (tumor necrosis factor-related apoptosis-inducing ligand/superparamagnetic iron oxide nanoparticle) nanocomplex hydrogels (T/S-NH) were used in combination with mild multiple MHT and MHT-mediated TRAIL release, with the aim of killing TRAIL-resistant glioblastoma multiforme cells [55] . Hyperthermia can enhance the release of TRAIL from hydrogels through temperature-sensitive hydrogel dissolution. TRAILresistant U-87 MG cells were killed by the combination of TRAIL and multiple hyperthermia via caspase-3 and -8 active apoptosis. The hyperthermia enhanced cytotoxicity of TRAIL was dependent on the hyperthermia cycle number and corresponding TRAIL release. Significant in vivo tumor reduction was observed by combining 2 cycles of mild MHT and TRAIL release using a single injection of TRAIL/SPION nanocomplex hydrogels without damage to main organs (Fig. 4b) .
Molecularly imprinted polymer
When molecularly imprinted polymers (MIPs), a templating process at the molecular level, were first described several decades ago [56] [57] [58] , they were mostly used as separation materials in analytical chemistry. MIPs are prepared in presence of a template that serves as a mold for the formation of template complementary binding sites. The resulting molecularly imprinted polymers are being used in a wide range of applications, such as chiral separation [58, 59] , chemical sensing [60, 61] , competitive drug assays [62] , chemical catalysis [63] , or solid phase extraction [64, 65] . MIP synthesis is reproducible, fast and economic. They are physically and chemically very stable, they are not easily degraded by proteases or denatured by solvents, and they can be engineered and tailored for a given application. In principle, MIP can be obtained for any target, even when no natural receptor or antibody exists.
Furthermore, the advantage of such a system is the possibility to integrate a drug inside the polymer and regulate the drug release by increasing the residence time of the therapeutic agent within the polymeric matrix, by means of either covalent or non-covalent interactions in specific binding sites. In this context, a new potential application of MIP in controlled drug release has attracted considerable attention [66] [67] [68] [69] [70] . Although imprinted drug delivery systems have not reached clinical application yet, this technology has an enormous potential for creating satisfactory dosage forms. Several works have been reported to prepare MIPs with different morphologies as delivery carriers to control release of drugs, such as monoliths, granules, membranes and microspheres [71] [72] [73] [74] . However, the best shape of MIPs may be the spherical one due to their excellent isotropic release capacity [75] . Since the surface area per unit volume of a material is inversely proportional to the size of the material, nanosize MIPs have enormous binding capacity. The small size of nanoparticles also enables those materials to be considered for therapeutic applications such as injection into the blood stream of living animals. In 2010, K. Shea et al. proposed molecular imprints in polymer nanoparticles for the toxic peptide melittin, the main component of bee venom. They created artificial antibodies that can be used for the in vivo capture and neutralization of melittin [76] . They showed that polymer particles are compatible with the aqueous environment in living organisms, have readily accessible binding sites for the target, and are able, like real antibodies, to neutralize its toxic effect.
It is only recently that novel stimuli such as UV illumination or AMF were employed for drug release from MIP. For example, asymmetric MIP particles (Janus particles) synthesized via a wax−water Pickering emulsion were suggested as self-propelled transporters for controlled drug delivery [77] . Release of the drug from the Janus MIP particles can be controlled by switching on−off the UV illumination. But this system lacks biocompatibility due to the use of Ag NPs and the limitation of UV illumination which damages cells. Therefore, there is a demand of adjustment for practical applications.
Concerning the magnetic MIPs, they have emerged as powerful materials for controlled drug delivery systems because they can be localized to the pre-delivery sites and release the drug to particular sites by the external magnetic field [78] . Hence, nanospherical magnetic MIPs should be suitable as an ideal polymer material for wider applications. Nonetheless, few studies have been reported on the preparation of nanospherical magnetic MIPs [79, 80] and only five studies have been reported about the controlled release of drugs by nanospherical magnetic MIPs. It is only in 2015 that Griffete et al. [81] developed an innovative magnetic delivery nanomaterial for triggered cancer therapy showing active control over drug release by using an alternative magnetic field. The material, which combines the controlled drug release ability of non-thermosensitive MIPs with magnetic properties of iron oxide, allows the controlled release of doxorubicin. Upon AMF exposure, the hydrogen bonds between the MIP and the DOX are broken and the molecule is released without any significant heating of the medium. This strategy is efficient for in cells experiments (Fig. 5) . These nanomaterials offer great promise for the doxorubicin release under a magnetic field and moreover we think that this approach will be easily expanded to other polymers, targeting molecules or drugs. The use of MIP for drug delivery under an alternative magnetic field is a major advance in the development of multifunctional targeted drug delivery nanotechnologies and may become an important theranostic tool in nanomedicine. The list of reports dealing with the elaboration of magnetic and polymeric nanosystems for drug release under an AMF are summarized in Table 1 .
Increasing the heat delivered per nanoparticles
As discussed previously, compared to other physical stimuli, MHT is an attractive physical modality for biomedical applications such as drug delivery and thermal therapy. However, despite such advantages, MHT is still facing some limitations related to the fact that the used superparamagnetic MNPs suffer from relatively low heat-generating efficiency. Given the limit of allowed magnetic field strength for living organs and the injectable dosage of MNPs there is a strong need for the development of NPs with optimized heating efficiency to achieve the necessary application. The most investigated strategy is based on modulation of the design of the MNPs to improve heat generation. In such direction several groups reported on the synthesis of MNPs where the magnetization and/or the anisotropy and/or the size have been modulated to enhance the Specific Absorption Rate (SAR). Comprehensive reviews on the recent advances for magneto-thermal capabilities of nanoparticles dealing with design principles and biomedical applications have been recently published [85] [86] [87] [88] . Another engineering alternative is based on the design of nanocombined inorganic based therapies including several components which can be physically and remotely stimulated and can develop synergistic properties. Magnetoplasmonic nanoplatforms combining the advantages of MHT and PTT are one of the most recent strategies and will be developed in this section.
Magnetoplasmonic NPs
If MNPs are the best candidate for applications in hyperthermia, the last 20 years have witnessed an increase in the number of publications showing the efficiency of plasmonic materials as powerful thermal agents for applications in cancer therapy and drug delivery. Plasmonic nanoparticles such as gold (Au) and silver (Ag), have fascinating physical, chemical and optical properties resulting from the spatial confinement of the electrons at the nano-scale. When the wavelength of an incoming light applied on the surface of metallic nanoparticles is much larger than the nanoparticle size, its electron cloud will resonate. The electrons of the nanoparticle will collectively oscillate in the conduction band in resonance with the light's frequency [89] . As a result, the electron cloud is displaced relative to the nuclei, so the surface remains charged positively where the cloud is lacking electrons and negatively where they are concentrated [90] (Fig. 6 ). This collective oscillation of all the electrons is called plasmon band, in contrast to bulk materials, where electrons are not allowed to travel through the material [91] . The excitation phenomenon on the metal nanoparticle surface is called localized surface plasmon resonance (LSPR). The LSPR has two main characteristics: an enhancement of the electric field near the particles' surface (which is higher at the surface and become lower with distance) and a maximum optical extinction at the plasmon resonance frequency [92] . The shape, the size and the surrounding medium [93] [94] [95] [96] [97] are all parameters that can affect the LSPR. Consequently the synthesis of plasmonic materials can be modulated to obtain optical responses in the near infrared window where light scattering effects are minimized by tissues, thus suitable for biomedical applications [98] [99] [100] [101] . Among plasmonic materials Au nanoparticles are the most used and reported probably because of their high biocompatibility, chemical stability and the rich surface chemistry of Au which make them powerful nanoplatforms for biomedical applications. Consequently, this section of the review will first focus on gold based magnetoplasmonics. For applications in the biomedical field, numerous morphologies with suitable LSPR have been elaborated including gold nanorods [102] , truncated octahedral [103] , nano-pearl necklaces [104] , nanostars [105] , nanoeggs [106] , nanoflowers [107] . Their optical properties allowed their applications as biosensors, contrast agents or in surface enhanced Raman spectroscopy [108] [109] [110] [111] [112] . Moreover due to their high total extinction coefficients and their capacity to convert into heat the strong absorption of light, gold nanoparticles are more efficient in photothermia than magnetic particles in MHT, and largely used for applications in cancer therapy or in drug delivery [113] [114] [115] . Besides, gold nanoparticles could overcome some of the challenges faced by MHT, including the low heat yield generated/ MNP and the low chemical stability of iron oxides in the intracellular environment [116] . However, MHT still offers numerous advantages such as no depth limitations in tissues, magnetic manipulation and targeting. Combining both materials into one single nanohybrid through the elaboration of optimized multifunctional magnetoplasmonic nanoplatforms may allow not only to inherit from the two components excellent surface chemistry, special optical properties, and superparamagnetic properties but also to hurdle some limitations of MHT through the development of synergies resulting from their association.
Synthesis of magnetoplasmonic nanohybrids
To design such magnetoplasmonic multicomponent hybrid nanoparticles, self-assembly or molecular bottom up approaches can be used and their synthesis have been very recently reviewed elsewhere [117] . The resulting nanohybrids can be summarized into three main designs ( Fig. 7) : particles embedded into a biocompatible polymer or silica compartment, core/shell materials, or heterodimeric structures [109, 118] , which both can be obtained through the seed growth strategy.
Among such structures, the magnetoplasmonic core@shell ones are the most widely reported morphologies in the literature. This is because core/shell structures are easily tunable as their size and shape can be tailored to reach higher control over their optical and physical properties. The shell layer protects the core from oxidation and enhance stability and biocompatibility [109, 126] but also permits further surface functionalization [127] [128] [129] . Depending on the structure of the coating layer, core/satellite nanoparticles, characterized by a single core with the attachment of numerous smaller nanoparticles can be distinguished from core/shell nanoparticles, which possess fully covered surface due to shell coating [109, 130] . Focusing on the synthesis of this type of nanoparticles, different chemical and physical approaches have been proposed to prepare them. However, the most used one is the chemical deposition process, which consists in the direct deposition of seeds on already prepared cores followed by a controlled growth of the seeds to form a more or less continuous coating around them [118] . Referring to the nature of the core, two types of magnetoplasmonic nanoparticles can be distinguished: those with a single or multiple magnetic core, mainly magnetite or maghemite which have been deeply investigated and successfully synthesized, and nanoparticles having a plasmonic core, usually formed by silver or gold metals [109, 118] . Incorporating the plasmonic component inside the magnetic shell represents a synthetic challenge as the difference in the surface energies could give rise to the segregation of the plasmonic and magnetic component [131] . Moreover the optical and physical properties of the plasmonic part can be inactivated in such structure [132, 133] .
Magnetoplasmonic Fe 3 O 4 @au for thermal therapies
Concerning the applications of magnetoplasmonic nanohybrids as nanothermal agents, although different architectures have been reported (Table 2 ) surprisingly and in majority only the plasmonic part has been investigated for hyperthermia applications. The iron oxide component has been mainly used as a MRI agent or for magnetic manipulation and targeting [128, [134] [135] [136] [137] . Fan et al. [138] developed S6 aptamer-conjugated magnetic core plasmonic shell nanoparticles for the targeted diagnosis, isolation, and photothermal destruction of SK-BR-3 human cancer cells. During the photothermal destruction of SK-BR-3 cancerous cells bound to S6 aptamer-conjugated magnetic/ plasmonic nanoparticles, the localized heating that occurs due to the absorption of 670 nm continuous NIR irradiation is able to cause irreparable cellular damage; it selectively kills most of the cancerous cells within 10 min at 2.5 W/cm optimized magnetoplasmonic nanoplatforms for applications in combined bimodal magnetic hyperthermia and plasmonic photothermia is very recent. In 2013 Abdulla-Al-Mamun and collaborators proposed core@shell nanostructures formed by magnetic nanocubes and a gold ultrathin layer for hyperthermia-photothermal activity. [121] The magnetic core of the nanoheaters was prepared by a colloidal method and the gold shell was synthesized by seed growth. It was demonstrated under the simultaneously combined magnetic field and photoirradiation with Fe 3 O 4 @Au a much higher HeLa cells killing than when both external stimuli are applied separately (Fig. 8.I) .
In 2015 an optimized magnetoplasmonic core/shell structure associating a magnetic nanoflower core optimized for MHT and a multibranched gold shell optimized for photothermia was designed by our group [139] . Once again, the aim is to overcome the limitations of magnetic hyperthemia by photothermia while allowing magnetic manipulation and targeting. The versatility of the system in generating heat through a remarkable cumulative effect when both magnetic and plasmonic modalities were applied simultaneously was demonstrated and showed for the first time that the heating efficiency was maintained under in vivo conditions. The tumor temperature can then rapidly reach 48°C, a condition for therapeutic tumor ablation, with a dose injected 10 times lower than that for classical MHT treatment (Fig. 8.  II) . Besides, such core/shell structure brings the additional advantage of providing the hybrid with a biostability overcoming the one of MNPs alone, and thus maintaining the thermal efficiency on the longterm, in the intracellular environment [141] . More recently Lu et al. (Fig. 8.III ).
Conclusion and outlook
Despite the recent progress in heat generating MNPs, challenges need to be addressed for the biomedical applications of magnetothermal effects of MNPs in biological systems. Although local thermal effect is very appealing for the next generation of magnetic carriers, these systems still need more investigations toward the understanding of very specific effects. Similarly, the "hot-spot" effect has been explored and its effect was deduced indirectly from macroscopic measurements, yet the local temperature profile around the nanoparticles still requires to be fully documented and understood. In brief, different approaches were conducted to demonstrate first indirect effects of the local heating process. Then, measurements were achieved with various probes to provide the temperature gradient at the surface of MNPs, at different spatial resolution. However, experiments that could give the temperature gradient from the MNPs surface to far apart (few hundred nanometers) are still missing. There also remains plenty to be done concerning the modeling of the nanoscale temperature gradient to confront experimental data depending both on the nature of magnetic particles (free processing or Brownian rotation) and on magnetic stimulation conditions. It would also be quite interesting to measure the nanoscale thermal effect under MHT coupled to methods as dynamic light scattering where the scattering coefficient could indicate the local variation of temperature around nano-antennas [148] .
Macromolecular polymers are flexible and efficient nanoplatforms for drug encapsulation and delivery compared to inorganic nanoparticles. However, despite the large portfolio of thermoresponsive nanosystems tested in vitro, only few studies have demonstrated the efficacy of AMF for in vivo drug release. Moreover, the mechanism of molecule release can be very complex. Understanding the diffusion of molecules through the matrix, swelling of the matrix and the chemical reactivity between the molecules and polymer chains (formation of hydrogen bonds, or electrostatic interactions) would be necessary to modulate and regulate the amount of drug released by such platforms [149] [150] [151] .
On the level of MIPs for drug delivery applications, since the devices are used in an aqueous environment, it would be generally preferable to carry out the imprinting in water. Practical demonstrations of imprinting in water have thus been rather limited to date. Among the best examples of molecular imprinting in aqueous environment are those following the studies of Tanaka et al. [152] . Similar approaches can thus be adopted in the design of MIPs to be used in biological media. In addition, biodegradable polymers, and the potential for biodegradable MIPs, would provide further flexibility in polymer morphology and the resulting dosage form.
It is also desirable to control pore size and volume in these crosslinked gels, perhaps in a way that allows the pores to be opened and closed in response to a local change.
Concerning the global efficacy of thermal treatments, it should be noted that, while a great number of reports have considered the modulation of the magnetic properties for increasing MHT through the design and synthesis of MNPs, recently, MNPs have also been envisaged as promising agents for photothermal therapy [153] [154] [155] .
Besides, Espinosa et al. [140] have demonstrated the amplification of heating efficiency by MHT and PTT bimodal treatment using magnetite iron oxide nanocubes. Further understanding of the mechanisms behind the heating and the design of stable magnetite NPs toward oxidation may allow to enlarge the panel of applications.
Gold based magnetoplasmonic materials seem also a promising approach and alternative to hurdle the limitations of MHT. However, to date their applications are still limited to the NIR-I window where scattering is strong in biological media. Semiconductor and plasmonic nanoparticles such as substoichiometric copper sulfide compounds (Cu 2-x S) may represent concurrent candidates for efficient PTT, as well as photo-acoustic imaging with deep penetration [156] . Compared to available gold nanoparticles with dimensions suitable for biomedical applications, Cu 2-x S semiconductor nanomaterials exhibit fine-tune localized surface plasmon resonance and large extinction coefficients in the second NIR biological window (NIR-II). In this region the imaging resolution (signal-to-noise ratio) is high and light has its maximum depth of penetration in tissues due to the reduction in the intensity of auto fluorescence and the absorption/scattering of photons [157] . Moreover, copper sulfide is biodegradable and its synthesis cost is much cheaper than gold (1 mol of CuS is US $330, and 1 mol of Au costs US $52,200) [158] , which is an important criteria for clinical translation and long-term applications. Such plasmonic semiconductors may also allow to combine other modalities on the same nanohybrid for multitherapy such as photodynamic therapy (PDT) while decreasing the dose in NPs.
